Compare TFX & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFX | RDNT |
|---|---|---|
| Founded | 1943 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | 1994 | 1996 |
| Metric | TFX | RDNT |
|---|---|---|
| Price | $139.67 | $74.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $138.75 | $82.80 |
| AVG Volume (30 Days) | 579.7K | ★ 685.2K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $1,992,713,000.00 | $1,616,630,000.00 |
| Revenue This Year | $15.97 | $22.78 |
| Revenue Next Year | $5.15 | $10.70 |
| P/E Ratio | $66.21 | ★ N/A |
| Revenue Growth | N/A | ★ 13.05 |
| 52 Week Low | $100.18 | $50.82 |
| 52 Week High | $145.00 | $85.84 |
| Indicator | TFX | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 55.32 | 56.41 |
| Support Level | $129.65 | $73.73 |
| Resistance Level | $145.00 | $74.55 |
| Average True Range (ATR) | 3.29 | 2.42 |
| MACD | 0.17 | -0.47 |
| Stochastic Oscillator | 79.80 | 13.50 |
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.